Cite
HARVARD Citation
Pagan, F. et al. (n.d.). Nilotinib is reasonably safe and may halt the disease progression in moderately severe Parkinson's disease patients. Parkinsonism & related disorders. pp. e71-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pagan, F. et al. (n.d.). Nilotinib is reasonably safe and may halt the disease progression in moderately severe Parkinson's disease patients. Parkinsonism & related disorders. pp. e71-. [Online].